Quilter Plc Cuts Stock Holdings in Stryker Co. (NYSE:SYK)

Quilter Plc reduced its holdings in Stryker Co. (NYSE:SYK) by 4.1% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 111,676 shares of the medical technology company’s stock after selling 4,736 shares during the period. Quilter Plc’s holdings in Stryker were worth $40,209,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Opal Wealth Advisors LLC grew its stake in shares of Stryker by 1.6% in the 4th quarter. Opal Wealth Advisors LLC now owns 1,816 shares of the medical technology company’s stock worth $654,000 after buying an additional 28 shares in the last quarter. Wingate Wealth Advisors Inc. purchased a new position in shares of Stryker during the 4th quarter worth about $78,000. Savant Capital LLC boosted its stake in shares of Stryker by 8.5% during the 4th quarter. Savant Capital LLC now owns 7,592 shares of the medical technology company’s stock worth $2,734,000 after purchasing an additional 596 shares during the period. Harbour Trust & Investment Management Co boosted its stake in shares of Stryker by 1.1% during the 4th quarter. Harbour Trust & Investment Management Co now owns 42,831 shares of the medical technology company’s stock worth $15,421,000 after purchasing an additional 484 shares during the period. Finally, Canvas Wealth Advisors LLC boosted its stake in shares of Stryker by 4.4% during the 4th quarter. Canvas Wealth Advisors LLC now owns 1,859 shares of the medical technology company’s stock worth $669,000 after purchasing an additional 78 shares during the period. 77.09% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the stock. StockNews.com lowered shares of Stryker from a “buy” rating to a “hold” rating in a report on Thursday, January 30th. JMP Securities reiterated a “market perform” rating on shares of Stryker in a report on Tuesday, January 7th. UBS Group lifted their price objective on shares of Stryker from $366.00 to $370.00 and gave the company a “neutral” rating in a report on Wednesday, October 30th. JPMorgan Chase & Co. lifted their price objective on shares of Stryker from $420.00 to $445.00 and gave the company an “overweight” rating in a report on Wednesday, January 29th. Finally, The Goldman Sachs Group lifted their price objective on shares of Stryker from $384.00 to $427.00 and gave the company a “neutral” rating in a report on Thursday, January 30th. Five equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat, Stryker has an average rating of “Moderate Buy” and an average price target of $419.37.

Insider Buying and Selling at Stryker

In other news, Director Ronda E. Stryker sold 201,392 shares of the stock in a transaction on Friday, January 31st. The shares were sold at an average price of $392.24, for a total value of $78,993,998.08. Following the sale, the director now owns 3,642,075 shares in the company, valued at $1,428,567,498. This represents a 5.24 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 5.90% of the stock is currently owned by company insiders.

Stryker Trading Down 1.2 %

NYSE:SYK opened at $391.42 on Monday. The company has a quick ratio of 1.32, a current ratio of 1.95 and a debt-to-equity ratio of 0.59. Stryker Co. has a 52 week low of $314.93 and a 52 week high of $406.19. The stock has a market capitalization of $149.22 billion, a price-to-earnings ratio of 50.44, a PEG ratio of 2.98 and a beta of 0.96. The firm has a 50 day moving average of $377.23 and a 200 day moving average of $364.97.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.87 by $0.14. Stryker had a net margin of 13.25% and a return on equity of 23.58%. During the same quarter last year, the business posted $3.46 EPS. As a group, sell-side analysts anticipate that Stryker Co. will post 13.49 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Monday, March 31st will be paid a dividend of $0.84 per share. The ex-dividend date is Monday, March 31st. This represents a $3.36 dividend on an annualized basis and a yield of 0.86%. Stryker’s payout ratio is 43.30%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.